Olopatadine Hydrochloride
- Product NDC
- 69097-276
- 11-digit product format
- 690970276
- Labeler code
- 69097
- Product ID
- 69097-276_a9255a28-e19a-491c-90e0-e0aea891e25e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olopatadine Hydrochloride Ophthalmic Solution
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Cipla USA Inc.
- Application
- ANDA206087
- Marketing category
- ANDA
- Marketing start
- 2017-12-05
- Marketing end
- 0000-00-00
- Substance
- OLOPATADINE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-276-33 | 69097027633 | 2.5 mL in 1 BOTTLE, PLASTIC (69097-276-33) | 2.5 ml | 2017-12-05 | 0000-00-00 | No | No | Current |